All Categories
  • All Categories
  • Accessories
  • Accessories & More
  • Butters & Eggs
  • Camera & Video
  • Mornitors
  • Tablets
  • Laptops
  • Handbags
  • Headphone & Speaker
  • Herbs & botanicals
  • Vegetables
  • Shop
  • Laptops & Desktops
  • Watchs
  • Electronic

Lopinavir EP Impurity K

SZ CAT No SZ-L008012
CAS No 1623021-24-8
Mol.F. C37H48N4O5 
Mol.Wt. 628.8
Inv. Status In Stock

Chemical Name: (2R)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide (as per EP); (R)-N-{(2S,4S,5S)-5-[2-(2,6-Dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide (as per USP)

Synonym: Lopinavir D-Valine Diastereomer (USP)

Smiles: CC(C)[C@@H](N1CCCNC1=O)C(N[C@@H](CC2=CC=CC=C2)C[C@H](O)[C@@H](NC(COC3=C(C)C=CC=C3C)=O)CC4=CC=CC=C4)=O

Inchi: InChI=1S/C37H48N4O5/c1-25(2)35(41-19-11-18-38-37(41)45)36(44)39-30(21-28-12-7-5-8-13-28)23-32(42)31(22-29-14-9-6-10-15-29)40-34(43)24-46-33-17-16-26(3)20-27(33)4/h5-10,12-17,20,25,30-32,35,42H,11,18-19,21-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,35-/m0/s1

Stability indicative and cost effective creation and validation of analytical method of Lopinavir and Rilpivirine by high performance liquid chromatography
By Srinivas, L.; Jain, Neelu
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2021), 12(1), 786-792
Analytical methods development & validation for simultaneous estimation of lopinavir & ritonavir in pharmaceutical formulation by simultaneous equation method using UV spectrophotometry
By Jadhav, Sarika R.; Alhat, Hemant P.; Joshi, Suhas
From International Research Journal of Pharmacy (2018), 9(8), 57-62
Development and validation of forced degradation studies of lopinavir using RP-​HPLC and characterization of degradants by LC-​MS​/MS
By Bhavyasri, Khagga; Balaram, V. Murali; Nageswarao, R.; Rambabu, D.; Ajitha, M.
From International Journal of Chemical Sciences (2015), 13(1), 551-562